Performance of an oral fluid rapid HIV-1/2 test: Experience from four CDC studies

AIDS

Volumn 20, Issue 12, 2006, Pages 1655-1660

  Delaney, Kevin P ^a,e   Branson, Bernard M ^a   Uniyal, Apurva ^b   Kerndt, Peter R ^c   Keenan, Patrick A ^d   Jafa, Krishna ^a,e   Gardner, Ann D ^f   Jamieson, Denise J ^g   Bulterys, Marc ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Health Research Association   (United States)

^c STD Program   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

^g NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

HIV rapid test; HIV testing; Oral fluid; OraQuick; Screening

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ALGORITHM; ARTICLE; BLOOD; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FLUID INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PERFORMANCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

AIDS SERODIAGNOSIS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; REAGENT KITS, DIAGNOSTIC; SALIVA; SENSITIVITY AND SPECIFICITY;

EID: 33746702652     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000238412.75324.82     Document Type: Article

References (19)

1. Food and Drug Administration. FDA approves first oral fluid based rapid HIV test kit [press release]. Bethesda, Maryland: US Department of Health and Human Services; 2004 http://www.fda.gov/bbs/topics/news/2004/NEW01042.html Accessed 14 June 2006.
2. Centers for Medicare and Medicaid Services. Clinical Laboratory Improvement Amendments of 1988 (CLIA). Washington DC: US Department of Health and Human Services; 2004. 42 CFR Ch. IV § 493.
3. OraQuick Advance HIV 1/2 Antibody Test [package insert]. Bethlehem, Pennsylvania: Orasure Technologies, Inc.; 2004 http://www.orasure.com/uploaded/ 398.pdf?138&sec=2@subsec=2 Accessed 14 June 2006.
4. Gallo D, George R, Fitchen J, Goldstein A, Hindahl M. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. JAMA 1997; 277:254-258.
5. Centers for Disease Control and Prevention. Interpretation and use of the Western Blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989; 38:1-7.
6. Greby S, Frey B, Royalty J, Fanning M, Gornto J, Ruffo N, et al. Use of simple oral fluid HIV-tests in CDC-funded facilities. Program and abstracts of the XIV International Conference on AIDS, 2002.
7. Bulterys M, Jamieson D, O'Sullivan M, Cohen M, Maupin R, Nesheim S, et al. Rapid HIV-1 testing during labor: a multicenter study. JAMA 2004; 292:219-223.
8. Cohen M, Olszewski Y, Branson B, Robey M, Love F, Jamieson D, et al. Using point-of-care testing to make rapid HIV-1 tests in labor really rapid. AIDS 2003; 17:2121-2124.
9. Association of Public Health Laboratories. HIV Diagnostic Testing Utilization Survey Report. Washington, DC: Association of Public Health Laboratories; 2005 http://www.aphl.org/docs/hiv_survey_report.pdf Accessed 14 June 2006.
10. Centers for Disease Control and Prevention. Quality assurance guidelines for testing using the OraQuick Rapid HIV-1 Antibody Test. Atlanta, Georgia: US Department of Health and Human Services; 2003. http://www.cdc.gov/hiv/ rapid_testing/materials/QA_Guidlines_OraQuick.pdf Accessed 14 June 2006.
11. Clopper C, Pearson E. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934; 26:404-413.
12. Foglia G, Royster G IV, Wasunna K, Kibaya R, Malia J, Calero E, et al. Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory. J Clin Microbiol 2004; 42:3850-3852.
13. Nookai S, Sinthuwattannawibool C, Phanuphak P, George R. Evaluation of a rapid HIV 1/2 antibody assay that tests either oral fluid, whole blood or serum/plasma. Proceedings of the Eighth Conference on Retroviruses and Opportunistic Infections. Chicago, Illinois 2001.
14. Centers for Disease Control and Prevention. Notice to readers: protocols for confirmation of reactive rapid HIV tests. MMWR Morb Mortal Wkly Rep 2004; 53:221-222.
15. Centers for Disease Control and Prevention. Supplemental testing for confirmation of reactive oral fluid rapid HIV antibody tests. MMWR Morb Mortal Wkly Rep 2005; 54:1287-1288.
16. Wesolowski LG, Mackellar DA, Facente SN, Dowling T, Ethridge SF, Zhu JH, et al. Post marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 2006; 20:1661-1666.
17. Fiebig E, Wright D, Rawal B, Garrett P, Schumacher R, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-1879.
18. Spielberg F, Branson B, Goldbaum G, Lockhart D, Kurth A, Rossini A, et al. Choosing HIV counseling and testing strategies for outreach settings: a randomized trial. J Acquir Immune Defic Syndr 2005; 38:348-355.
19. Gift T, Pate M, Hook EI, Kassler W. The rapid test paradox: when fewer cases detected leads to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis 1999; 26:232-240.